| Financial Year |
March 31 2023 |
| Monetary Funds |
500,655,780.11 |
| Held-for-trading Financial Assets |
3,793,889.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
374,603,278.09 |
| Advances to Suppliers |
16,271,876.13 |
| Other Receivables |
17,616,564.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
617,355,364.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,030,394.81 |
| Total Current Assets |
1,591,327,147.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
101,050,400.76 |
| Fixed Assetes |
1,543,994,939.61 |
| Under-construction Projects |
53,647,858.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
254,454,108.42 |
| R&D expenses |
-- |
| Goodwill |
100,298,196.31 |
| Long-Term Deferred and Prepaid Expenses |
60,432,127.79 |
| Deferred Income Tax Assets |
13,799,829.81 |
| Other Non-Current Assets |
2,785,533.01 |
| Sub-Total of Non-Current Assets |
2,132,034,363.06 |
| Total Assets |
3,723,361,510.65 |
| Short-Term Loans |
545,661,865.49 |
| Trading Financial liabilities |
895,286.50 |
| Notes Payable |
112,347,352.10 |
| Accounts Payable |
92,015,824.20 |
| Accounts Received In Advance |
1,380,020.36 |
| Employee Compensation Payable |
56,916,395.95 |
| Taxes Payable |
19,464,998.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,241,352.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
250,414,373.69 |
| Other Current Liabilities |
35,186.88 |
| Sub-Total of Current Liabilities |
1,094,118,203.20 |
| Long-term Loans |
119,017,108.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,594,693.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
125,306,698.58 |
| Total Liabilities |
1,219,424,901.78 |
| Paid-In Capital(Or Share Stock) |
381,262,949.00 |
| Capital Surplus |
1,574,934,768.14 |
| Surplus Reserve |
76,730,091.91 |
| LESS:Treasury Stock |
38,059,536.86 |
| Undistributed Profits |
526,642,694.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,503,936,608.87 |
| Owner's Equity（Stockholder's Equity） |
2,503,936,608.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,723,361,510.65 |
